| Literature DB >> 34938982 |
Emily W Tow1, Mahmut Selim Ersan2, Soyoon Kum3, Tae Lee4, Thomas F Speth4, Christine Owen5, Christopher Bellona6, Mallikarjuna N Nadagouda4, Anne M Mikelonis7, Paul Westerhoff2, Chandra Mysore8, Val S Frenkel9, Viraj deSilva10, W Shane Walker11, Andrew K Safulko6, David A Ladner12.
Abstract
Per- and polyfluoroalkyl substances (PFAS), which are present in many waters, have detrimental impacts on human health and the environment. Reverse osmosis (RO) and nanofiltration (NF) have shown excellent PFAS separation performance in water treatment; however, these membrane systems do not destroy PFAS but produce concentrated residual streams that need to be managed. Complete destruction of PFAS in RO and NF concentrate streams is ideal, but long-term sequestration strategies are also employed. Because no single technology is adequate for all situations, a range of processes are reviewed here that hold promise as components of treatment schemes for PFAS-laden membrane system concentrates. Attention is also given to relevant concentration processes because it is beneficial to reduce concentrate volume prior to PFAS destruction or sequestration. Given the costs and challenges of managing PFAS in membrane concentrates, it is critical to evaluate both established and emerging technologies in selecting processes for immediate use and continued research.Entities:
Keywords: brine management; concentrate management; membranes; per- and polyfluoroalkyl substances; water treatment
Year: 2021 PMID: 34938982 PMCID: PMC8687045 DOI: 10.1002/aws2.1233
Source DB: PubMed Journal: AWWA Water Sci ISSN: 2577-8161
FIGURE 1Conceptual sketch of PFAS transport pathways from source to disposal or environmental release. Disposed streams and environmental waters may be subjected to further treatment for PFAS
FIGURE 2Conceptual sketch of membrane and concentrate treatment unit processes for PFAS-contaminated feed water
FIGURE 3(a) Foam fractionation column treating PFAS-laden water (photo courtesy of Evocra Pty Ltd). (b) Foam fractionation system (photo courtesy of OPEC systems and Dora Chiang, CDM Smith)
FIGURE 4Operation of industrial wastewater plant with electron beam. (a) Injection of wastewater through nozzles. (b) Wastewater under treatment (reprinted from [Han et al., 2012] with permission from Elsevier)
FIGURE 5Supercritical water oxidation reactor (photo courtesy of Aquarden Technologies)
High-level summary of various PFAS management technologies
| Technology | Advantages | Disadvantages | |
|---|---|---|---|
| Concentration | Reverse osmosis and nanofiltration | • Effective removal | • Membrane scaling limits recovery |
| Membrane distillation | • Effective removal of PFPeA | • Membrane fouling | |
| Forward osmosis | • High rejection and recovery possible | • Draw regeneration difficult | |
| RO-electrodialysis hybrids | • Possibly concentrate charged PFAS compounds | • No validation with PFAS | |
| Foam fractionation | • Effective removal of long-chain PFAS, including PFOS | • Less effective for short-chain PFAS | |
| Electrocoagulation | • Ease of operation | • Requires optimization ofoperational conditions | |
| Evaporation ponds | • Compatible with solar energy | • High land area requirement | |
| • ZLD possible | • PFAS emissions to air possible | ||
| Brine concentrators and crystallizers | • Significant concentration and ZLD possible | • High energy requirement | |
| Adsorption | • Reliable and easy to operate | • May require frequent regeneration and/or replacement of saturatedadsorbents | |
| Coagulant aids | • Early data show high effectiveness | • Proprietary formulations | |
| Defluorination | Biological treatment | • Could scale well | • Largely unsuccessful so far |
| Ultraviolet irradiation | • Availability of equipment | • Ineffective for PFAA | |
| Photocatalysis | • Effective degradation of PFOA | • May generate intermediates, such as PFHpA, PFHxA, PFPeA, PFBA, PFPA, and TFA | |
| Advanced oxidation | • Moderate success with FTOHs | • Limited success with PFAS | |
| Hydrated electrons | • Effective destruction of at least some PFAS | • Early stage | |
| Plasma-based treatment | • Early evidence of effective defluorination | • Early stage | |
| Electron beam | • High technology readiness level: previously used at full and pilotscales for wastewater and groundwater and commercially available in medical and pasteurization industries | • Large capital cost and high priceper volume treated | |
| • Effective at PFOA and PFOS degradation | |||
| Zero-valent iron | • Effective with carbonate PFAS | • Less effective with sulfonate PFAS | |
| Sonochemical treatment | • Complete mineralization of PFAS can be achieved without any pretreatment | • High energy input and scalability issues | |
| Incineration | • Effective in desorption/destruction of PFAS | • Formation of by-products | |
| Supercritical water oxidation | • Effective with many PFAS | • High temperature and pressure create operational challenges | |
| • Salts in membrane concentrates must be removed to prevent severescaling | |||
| Sequestration | Deep-well injection | • Reliable sequestration | • Nondestructive |
| Landfill | • Endpoint for solids | • Nondestructive |
Note: For references, see the relevant section of the narrative.
Abbreviations: FTOHs, fluorotelomer alcohols; PFAA, perfluoroalkyl acid; PFAS, per- and polyfluoroalkyl substances; PFBA, pentafluorobenzoic acid; PFHpA, perfluoroheptanoic acid; PFHxA, perfluorohexanoic acid; PFOS, perfluorooctane sulfonic acid; PFPeA, perfluoropentanoic acid; PFPA, perfluoropropanoic acid; RO, reverse osmosis; TFA, trifluoroacetic acid.
FIGURE 6Graphical summary of technology readiness levels (ITRC, 2020) and nominal reported potential to manage (separate, defluorinate, or sequester) PFAS from reverse osmosis concentrate. The relative placement of processes in the plot does not consider capital and operating costs, in part because these are challenging to estimate for early-stage technologies. Numbers correspond to the sections of this article where each technology is discussed